These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia. Gonçalves VF; Zai CC; Tiwari AK; Brandl EJ; Derkach A; Meltzer HY; Lieberman JA; Müller DJ; Sun L; Kennedy JL Neuropsychopharmacology; 2014 May; 39(6):1347-54. PubMed ID: 24196945 [TBL] [Abstract][Full Text] [Related]
9. Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans. Maciukiewicz M; Tiwari AK; Zai CC; Gorbovskaya I; Laughlin CP; Nurmi EL; Liebermann JA; Meltzer HY; Kennedy JL; Müller DJ Schizophr Res; 2019 Oct; 212():204-212. PubMed ID: 31447353 [TBL] [Abstract][Full Text] [Related]
10. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
11. Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene. Chowdhury NI; Tiwari AK; Souza RP; Zai CC; Shaikh SA; Chen S; Liu F; Lieberman JA; Meltzer HY; Malhotra AK; Kennedy JL; Müller DJ Pharmacogenomics J; 2013 Jun; 13(3):272-9. PubMed ID: 22310352 [TBL] [Abstract][Full Text] [Related]
12. Association of orexin receptor polymorphisms with antipsychotic-induced weight gain. Tiwari AK; Brandl EJ; Zai CC; Goncalves VF; Chowdhury NI; Freeman N; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ World J Biol Psychiatry; 2016 Apr; 17(3):221-9. PubMed ID: 26447462 [TBL] [Abstract][Full Text] [Related]
13. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Rummel-Kluge C; Komossa K; Schwarz S; Hunger H; Schmid F; Lobos CA; Kissling W; Davis JM; Leucht S Schizophr Res; 2010 Nov; 123(2-3):225-33. PubMed ID: 20692814 [TBL] [Abstract][Full Text] [Related]
14. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. Newcomer JW CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156 [TBL] [Abstract][Full Text] [Related]
15. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis. Smith RC; Leucht S; Davis JM Psychopharmacology (Berl); 2019 Feb; 236(2):545-559. PubMed ID: 30506237 [TBL] [Abstract][Full Text] [Related]
16. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study. Kahn RS; Winter van Rossum I; Leucht S; McGuire P; Lewis SW; Leboyer M; Arango C; Dazzan P; Drake R; Heres S; Díaz-Caneja CM; Rujescu D; Weiser M; Galderisi S; Glenthøj B; Eijkemans MJC; Fleischhacker WW; Kapur S; Sommer IE; Lancet Psychiatry; 2018 Oct; 5(10):797-807. PubMed ID: 30115598 [TBL] [Abstract][Full Text] [Related]
17. Genome-Wide Association Study Suggested the PTPRD Polymorphisms Were Associated With Weight Gain Effects of Atypical Antipsychotic Medications. Yu H; Wang L; Lv L; Ma C; Du B; Lu T; Jin C; Yan H; Yang Y; Li W; Ruan Y; Zhang H; Zhang H; Mi W; Mowry B; Ma W; Li K; Zhang D; Yue W Schizophr Bull; 2016 May; 42(3):814-23. PubMed ID: 26656879 [TBL] [Abstract][Full Text] [Related]
18. Second-generation antipsychotics for major depressive disorder and dysthymia. Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393 [TBL] [Abstract][Full Text] [Related]
19. A2BP1 gene polymorphisms association with olanzapine-induced weight gain. Dong L; Yan H; Huang X; Hu X; Yang Y; Ma C; Du B; Lu T; Jin C; Wang L; Yu H; Dong Z; Li W; Ruan Y; Zhang H; Zhang H; Mi W; Ma W; Li K; Lv L; Zhang D; Yue W Pharmacol Res; 2015 Sep; 99():155-61. PubMed ID: 26092620 [TBL] [Abstract][Full Text] [Related]